María del Pilar Herrera Puente-rekin lankidetzan egindako argitalpenak (12)

2024

  1. COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant

    Cancers, Vol. 16, Núm. 2

  2. Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia

    Frontiers in Oncology, Vol. 14

2023

  1. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

  2. Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry

    Hematological Oncology, Vol. 41, Núm. 4, pp. 753-761

2021

  1. Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19

    Bone Marrow Transplantation

  2. The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid

    Leukemia Research

2020

  1. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies

    British Journal of Haematology

2015

  1. Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: Phase Ib/II panobidara study

    Haematologica, Vol. 100, Núm. 10, pp. 1294-1300

2010

  1. Histología y biomarcadores en la enfermedad del injerto contra el huésped cutánea

    Methods and Findings in Experimental and Clinical Pharmacology, Vol. 32, Núm. SUPPL. A, pp. 19-23

2002

  1. La célula dendrítica: Características biológicas y aplicación clínica

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 5, Núm. 3, pp. 168-181

2000

  1. Autologous peripheral blood progenitor cell transplantation with <2×106 CD34+/kg: An analysis of variables concerning mobilisation and engraftment

    Hematology Journal, Vol. 1, Núm. 6, pp. 374-381

1998

  1. Enfermedad de von Willebrand: Caracteristicas y respuesta a desmopresina. Estudio de 103 casos

    Medicina Clinica, Vol. 111, Núm. 16, pp. 601-603